Minomic International
PrivateLast Round
Grant
Feb 2, 2022
Total Funding Raised
$1.09M
Company Overview
Minomic International operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Grant round in February 2022.
Minomic International is a biotechnology company that develops non-invasive diagnostic tests for cancer, including its flagship MiCheck® Prostate test for the risk assessment of clinically significant prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minomic International Comparables
Compare Minomic International with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LynxDx | 84% | |
| A3P Biomedical | 83% | |
| NucleoBio Corp | 82% |
For institutional investors. Book with your work email.
Minomic International Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2022 | ||||
| Grant | Nov 1, 2015 | ||||
| VC Round | Mar 8, 2012 |
For institutional investors. Book with your work email.
Minomic International Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Health and Medical Research Council | Grant |
| Australian Research Council | Grant |
| AMGC | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 169% MoM, reaching 2K.
- Apr 18, 2026
Monthly visitors grew 542% MoM, from 114 to 732.
For institutional investors. Book with your work email.
Minomic International Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Minomic International's valuation, stock price, and market status.
Is Minomic International a public or private company?
Minomic International is a private company.
What is the current stock price of Minomic International?
Minomic International is a private company, so its shares have no public market price. Caplight tracks Minomic International's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Minomic International worth (valuation)?
Valuation information for Minomic International is not publicly available.
Can I buy Minomic International stock?
Minomic International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Minomic International's last funding round?
Minomic International's most recent funding round was Grant on February 2, 2022.
Who are the main investors in Minomic International?
Key investors in Minomic International include National Health and Medical Research Council, Australian Research Council, AMGC.
Will Minomic International IPO soon?
No public IPO plans have been announced for Minomic International.
How can I track Minomic International secondary market activity?
Caplight tracks bids, offers, and trades in Minomic International's shares on secondary markets.